SYDNEY, Australia

BIOTRONIK and University of Sydney Partner to Transform Cardiac Care Through Digital Innovation

  • This Three-Year Collaboration Aims to Deliver Scalable Health Solutions for Improved Disease Management
  • The Initiative Hopes to Benefit Patients Particularly in Remote or Underserved Regions with Limited Access to Care

SYDNEY, Australia – BIOTRONIK, a global leader in medical technology, and the University of Sydney, one of the world’s top research and teaching institutions, have signed a Memorandum of Understanding (MoU) to jointly advance digital and connected health innovations through 2028.

By combining BIOTRONIK’s expertise in implanted cardiac devices and remote monitoring with the University of Sydney’s world-class research capabilities and the expertise of the Westmead Applied Research Centre (WARC) in patient-facing digital health tools, the collaboration aims to co-design solutions that address real-world clinical needs. This MoU marks a significant milestone in the evolution of patient-centered, value-based healthcare. 

“This MoU is about more than just technology. It’s about reimagining how we deliver care,” said Jan Ewert, Managing Director, BIOTRONIK Australia and New Zealand. “We aim to create digital tools that integrate into existing workflows and empower clinicians and patients to improve care provision and outcomes.”

As healthcare systems worldwide face increasing pressure from rising costs, an ageing population, workforce shortages, the need for low-cost technology and digital solutions has never been more urgent. Smart, scalable solutions such as remote monitoring and AI-driven decision support can help bridge care gaps, optimize resources, and enable earlier interventions especially for chronic conditions. 

Over the next three years, the partnership will focus on developing and clinically evaluating new tools in areas such as remote patient monitoring, AI, and clinical decision support. These innovations will be tested in real-world settings to ensure they deliver measurable value to both patients and healthcare systems. The initiative hopes to benefit patients particularly in remote or underserved regions with limited access to care.

“We are thrilled to deepen our relationship with BIOTRONIK to co-develop digital health solutions that are grounded in clinical evidence and designed with patient welfare at the heart,” said Professor Clara Chow AM, Professor of Medicine, Cardiologist (WSLHD), Academic Director (WARC) & Professor of Medicine at the Sydney Medical School. “It presents a unique opportunity to translate cutting-edge research into real-world impact for people living with cardiovascular disease.”

Cardiovascular disease remains the leading cause of death globally. Addressing this challenge requires cross-sector collaboration to translate research into practical, scalable solutions. This is aimed at accelerating progress, meeting the demands of modern healthcare.

-END-

 

About BIOTRONIK 

For over 60 years, BIOTRONIK has stood at the forefront of medical technology, pioneering breakthrough innovations that are transforming the lives of millions affected by heart disease and chronic pain. Rooted in a deep purpose to seamlessly harmonize technology with the human body, we engineer trusted, life-changing therapies through our advanced active implants in Cardiac Rhythm Management, Monitoring, and Neuromodulation, while providing cutting-edge solutions in Electrophysiology. From creating Germany’s first pacemaker in 1963 to breaking new ground in digital technologies and Conduction System Pacing today, BIOTRONIK is continuously raising the bar for quality, performance, and innovation. Headquartered in Berlin, our global reach spans over 100 countries across the Americas, EMEA, and Asia—bringing bold, future-ready solutions that are shaping the next generation of medical technology.    

Media Contact

BIOTRONIK Press Office: press@biotronik.com  

 

About the University of Sydney

As Australia’s first university – founded in 1850 – the University of Sydney has been sharing knowledge, empowering students and addressing the world’s most complex challenges for 175 years. Currently ranked first in Australia (US News) and joint 25th in the world (QS World University Rankings), we’re consistently placed among the best universities and globally renowned for our teaching and research. Westmead Applied Research Centre (WARC), a Sydney Medical School, Faculty of Medicine & Health Impact Centre, was established by the University of Sydney in collaboration with the Western Sydney Local Health District to create and apply innovation to addressing chronic health conditions. WARC brings together multidisciplinary experts to co-design, evaluate and translate innovative solutions into healthcare and prevention. It partners with industry, government, and not-for-profit organisations.

 

Media Contact

Luisa Low | Senior Media & PR Adviser
The University of Sydney                                           
Media and Public Relations                   
+61 438 021 390 | luisa.low@sydney.edu.au | sydney.edu.au 

    Captions

    Photo 1 

    Front row (from left to right): Rahul Sathiaraj, Digital Health Project Manager (WARC, The University of Sydney), Prof Clara Chow AM, Professor of Medicine, Cardiologist (WSLHD), Academic Director (WARC) & Professor of Medicine (Sydney Medical School), Jan Ewert, Managing Director (BIOTRONIK Australia and New Zealand), Dr Julius Juarez, Commercialisation Theme Leader (Commercialisation Office, The University of Sydney), Dr Naveed Khan, Senior Program Lead Digital Health (BIOTRONIK Australia and New Zealand)

    Back row (from left to right): Dr Edel O'Hagan, Research Fellow (WARC, The University of Sydney), Sally McNeill, Senior Project Officer (WARC, The University of Sydney), Dr Simone Marschner, Senior Research Fellow and Head Biostatistician (WARC, The University of Sydney), Dr Desi Quintans, Statistical Programmer (WARC, The University of Sydney), Dr Anushriya Pant, Research Fellow (WARC, The University of Sydney), Zoe Rock, Research Officer (WARC, The University of Sydney), Vishal Gopal, Clinical Trials Services Manager (WARC, The University of Sydney)

    Photo 2

    Front row:  Prof Clara Chow AM, Professor of Medicine, Cardiologist (WSLHD), Academic Director (WARC) & Professor of Medicine (Sydney Medical School) and Jan Ewert, Managing Director (BIOTRONIK Australia and New Zealand)

    Back row: Rahul Sathiaraj, Digital Health Project Manager (WARC, The University of Sydney) and Dr Naveed Khan, Senior Program Lead Digital Health (BIOTRONIK Australia and New Zealand)

    Photo 3

    Prof Clara Chow AM, Professor of Medicine, Cardiologist (WSLHD), Academic Director (WARC) & Professor of Medicine (Sydney Medical School) and Jan Ewert, Managing Director (BIOTRONIK Australia and New Zealand)